Home
News
- 1 Pfizer stock price surged more than 5% in the last three Intraday sessions.
- 2 Pfizer share (NYSE: PFE) price is trying to recover from a three-year low price.
- 3 The daily chart illustrates a divergence indicating the bullish movement possible in the stock.
Pfizer Inc. stock price has witnessed an upthrust in the past three sessions and has gained more than 5% in the period. The stock price showed bullishness after slipping below a three-year low price of $31.77.
The price trend analysis demonstrates that the short-term trend as well as long-term trend favored the bears. The PFE stock price has been on a declining trend from the very start of the year 2023. The price fell from a high of $50 and made a breakdown to hit a record three-year low price of $31 wiping out over 30% of its market value on a year-to-date basis.
Recently, the Pfizer share price has shown some strength and recovered 5%. The stock price seems to have gained momentum which might help it to surge further upwards. October can be a game changer for the stock price and the price might show more gains in the upcoming sessions to recover the decline.
However, the price trend favors the bears at the moment. The PFE stock investors must try and surpass the upper supply zone to turn the trend in their favor. Moreover, it requires more buying volume to accumulate at the lower demand zone.
Pfizer stock derivatives data analysis states that the current implied volatility in the market is 31.12% with an increment of 1.15% in the last trading session. The at-the-money strike price has 5,018 open contracts on the PUT side and 7,044 open contracts on the CALL side indicating the dominance of sellers at the CMP.
Pfizer Stock Price Forecast For 2023
The average analyst price target for Pfizer stock in 2023 is $49.26, which represents a potential upside of 14.91% from the current price. However, there is a wide range of analyst price targets from $43.00 to $54.00.
The most optimistic analysts believe that Pfizer stock could reach $54.00 in 2023 if the global pharmaceutical industry grows strongly and Pfizer is able to successfully launch new products.
Technical Indicators Signal Momentum in Buying
The overall technical indicators including RSI and MACD opinion rating for the PFE stock is a 60% “sell” with a weakening short-term outlook on maintaining the current trend.
Conclusion
Pfizer Inc.’s stock price has gained over 5% in the past three sessions after falling to a three-year low. The price trend is bearish in the short and long term, but the recent strength may indicate a reversal. October could be a game-changer for the stock but investors must try to surpass the upper supply zone and accumulate more buying volume at the lower demand zone to turn the trend in their favor. The average analyst price target for Pfizer stock in 2023 is $49.26, with a wide range of targets from $43.00 to $54.00.
Technical Levels
- Support Levels: $32.92 and $32.01
- Resistance Levels: $34.67 and $36.11
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.
Nancy J. Allen is a crypto enthusiast, with a major in macroeconomics and minor in business statistics. She believes that cryptocurrencies inspire people to be their own banks, and step aside from traditional monetary exchange systems. She is also intrigued by blockchain technology and its functioning. She frequently researches, and posts content on the top altcoins, their theoretical working principles and technical price predictions.
